GILD · Gilead Sciences, Inc.

$129.35 -1.51 (-1.15%) At close · Jul 24

Market Cap

$160.55B

1.24B

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Daniel P. O’Day	CEO	$1,795,192	—	$15,238,402	$4,500,060	$4,848,120	$2,055,424	$28,437,198
Dietmar Berger	Chief Medical Officer	$969,231	$3,000,000	$6,999,758	$1,000,043	$1,603,594	$350,252	$13,922,878
Johanna Mercier	Chief Commercial Officer	$1,182,269	—	$4,564,517	$1,299,976	$2,150,901	$102,980	$9,300,643
Andrew Dickinson	CFO	$1,116,654	—	$4,321,741	$1,299,976	$1,956,266	$70,979	$8,765,616
Deborah H. Telman	General Counsel	$977,334	—	$3,071,792	$900,065	—	$55,478	$5,004,669

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Daniel P. O’Day	CEO	$1,771,201	—	$12,426,816	$4,125,011	$4,028,096	$1,338,268	$23,689,392
Johanna Mercier	Chief Commercial Officer	$1,148,038	—	$4,139,594	$1,300,029	$1,845,246	$176,158	$8,609,065
Merdad Parsey	Chief Medical Officer	$1,141,486	—	$4,206,347	$1,325,004	$1,410,810	$27,484	$8,111,131
Andrew Dickinson	CFO	$1,083,969	—	$4,080,024	$1,300,029	$1,608,840	$36,896	$8,109,758
Deborah H. Telman	General Counsel	$967,723	—	$2,151,425	$812,500	$1,436,148	$704,083	$6,071,879

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Daniel P. O’Day	CEO	$1,740,962	—	$11,865,090	$3,749,966	$4,036,200	$1,215,472	$22,607,690
Johanna Mercier	Chief Commercial Officer	$1,114,035	—	$4,190,733	$1,299,966	$1,805,440	$176,580	$8,586,754
Merdad Parsey	Chief Medical Officer	$1,108,215	—	$4,269,768	$1,324,984	$1,657,632	$26,248	$8,386,847
Andrew Dickinson	CFO	$1,052,396	—	$4,143,271	$1,299,966	$1,574,304	$37,886	$8,107,823
Deborah H. Telman	General Counsel	$936,865	—	$1,895,703	$812,512	$1,288,980	$337,168	$5,271,228

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Daniel P. O’Day	CEO	$1,691,154	—	$10,603,901	$3,750,014	$4,716,480	$859,704	$21,621,253
Johanna Mercier	Chief Commercial Officer	$1,081,471	—	$4,301,757	$1,612,496	$1,995,732	$244,997	$9,236,453
Merdad Parsey	Chief Medical Officer	$1,072,800	—	$4,350,004	$1,612,496	$1,986,552	$15,362	$9,037,214
Andrew Dickinson	CFO	$1,018,419	—	$3,992,603	$1,474,983	$1,885,572	$31,121	$8,402,698
Deborah H. Telman	General Counsel	$380,769	$1,200,000	$1,999,890	$499,979	$536,548	$205,763	$4,822,949

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Daniel P. O’Day	CEO	$1,650,000	—	$9,764,060	$3,375,004	$3,446,190	$994,212	$19,229,466
Johanna Mercier	Chief Commercial Officer	$1,050,428	—	$2,620,663	$1,012,485	$1,557,231	$311,790	$6,552,597
Merdad Parsey	Chief Medical Officer	$1,024,808	—	$2,773,579	$1,062,502	$1,640,790	$15,000	$6,516,679
Andrew Dickinson	CFO	$973,567	—	$2,862,493	$1,049,984	$1,558,751	$15,000	$6,459,795
Brett A. Pletcher	General Counsel	$973,567	—	$2,320,424	$800,006	$1,443,288	$52,746	$5,590,031

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Daniel P. O’Day	CEO	$1,702,885	—	$8,388,056	$3,125,041	$4,713,390	$1,068,723	$18,998,095
Johanna Mercier	Chief Commercial Officer	$1,059,135	$1,600,000	$2,042,265	$874,968	$1,980,300	$220,243	$7,776,911
Merdad Parsey	Chief Medical Officer	$1,038,462	$1,000,000	$2,332,860	$1,000,033	$1,794,000	$15,000	$7,180,355
Andrew Dickinson	CFO	$986,538	—	$2,260,949	$874,968	$1,704,300	$15,000	$5,841,755
Brett A. Pletcher	General Counsel	$986,538	—	$2,212,188	$750,025	$1,704,300	$15,000	$5,668,051

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Daniel P. O’Day	CEO	$1,267,692	$5,675,000	$15,500,541	$3,000,002	$3,120,000	$544,619	$29,107,854
Johanna Mercier	Chief Commercial Officer	$461,538	$1,250,000	$3,751,166	$1,750,097	$650,000	$186,585	$8,049,386
Gregg H. Alton	—	$952,627	—	$4,244,989	$1,329,547	$1,304,625	$12,000	$7,843,788
Laura J. Hamill	Former Executive Vice President Worldwide Commercial Operations John G. McHutchison, Former Chief Scientific Officer, Head of Research and Development	$520,211	—	$2,188,001	$937,433	—	$4,026,797	$7,672,442
Robin L. Washington	CFO	$1,064,615	—	$2,893,782	$999,978	$1,370,630	$12,000	$6,341,005
Andrew Dickinson	CFO	$802,308	$1,000,000	$1,708,267	$1,000,096	$1,086,800	$12,000	$5,609,471
Brett A. Pletcher	General Counsel	$891,000	—	$2,144,734	$749,946	$1,235,000	$12,000	$5,032,680
Merdad Parsey	Chief Medical Officer	$119,231	$1,000,000	$1,000,314	$1,000,008	—	—	$3,119,553

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Laura J. Hamill	Former Executive Vice President Worldwide Commercial Operations John G. McHutchison, Former Chief Scientific Officer, Head of Research and Development	$292,308	$1,500,000	$6,500,604	$1,500,003	$431,778	$113,133	$10,337,826
Robin L. Washington	CFO	$1,011,750	—	$1,945,494	$2,000,006	$1,375,421	$10,000	$6,342,671
Former Interim Chief	Executive Officer and Chief Patient Officer	$1,005,381	—	$1,431,174	$1,250,078	$1,210,230	$10,000	$4,906,863

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Robin L. Washington	CFO	$953,231	—	$1,613,500	$1,800,015	$1,152,600	$10,000	$5,529,346
Former Interim Chief	Executive Officer and Chief Patient Officer	$956,308	—	$1,518,203	$1,599,915	$1,132,000	$10,000	$5,216,426

Key facts CIK 882095 CUSIP 375558103 13F (30d) 731 filings 698 filers Visit website Investor relations